Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair

NCT03208920
completednot_applicable

The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention

NCT02096757
completedphase_2

The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

NCT01979874

Clinical Trials (3)

Showing 3 of 3 trials
NCT03208920Not Applicable

Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair

Completed
NCT02096757Not Applicable

The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention

Completed
NCT01979874Phase 2

The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3